Synutra Participates in the China-France Business Forum
QINGDAO, China and ROCKVILLE, Md., May 3, 2013
QINGDAO, China and ROCKVILLE, Md., May 3, 2013 /PRNewswire/ -- Synutra
International, Inc. (NASDAQ: SYUT), ("Synutra" or the "Company"), which owns
subsidiaries in China that produce, market and sell nutritional products for
infants, children and adults, announced that on April 25^th, 2013, the
Company's Chairman and CEO, Mr. Liang Zhang participated in the China-France
Business Forum in Beijing, China.
At the Forum, Mr. Zhang delivered a speech about the Company's agreement with
Sodiaal, Synutra's partner involved in the development of a new drying
facility in Carhaix, France, which intended to manufacture powdered milk and
fat-enriched demineralized whey for the Company. Additionally, under the
witness of Chinese President Xi Jinping and French President Francois
Hollande, Mr. Zhang signed an implementation agreement with Sodiaal's
Chairman, Mr. Gerard Budin related to its industrial and commercial
The China-France Business Form was organized by Chinese Ministry of Commerce,
the Trade Development Council and France-China Committee. Chinese President Xi
Jinping and his visiting French counterpart Francois Hollande participated in
the forum and made their closing remarks. The purpose of the Forum was to
identify ways for the two countries to work together to improve business ties
and boost economic prosperity.
Mr. Liang Zhang, Chairman and CEO of Synutra, commented, "It's a great honor
to participate in this high-profile business forum with select companies and
top political representatives from both countries. We are pleased to move
forward with the development of our French drying facility, and we believe
that, when completed, our drying facility will enable Synutra to maintain the
highest quality product standards."
About Synutra International, Inc.
Synutra International, Inc. (Nasdaq: SYUT) is a leading infant formula company
in China. It principally produces, markets and sells its products through its
operating subsidiaries under the "Shengyuan" or "Synutra" name, together with
other complementary brands. It focuses on selling premium infant formula
products, which are supplemented by more affordable infant formulas targeting
the mass market as well as other nutritional products and ingredients. It
sells its products through an extensive nationwide sales and distribution
network covering all provinces and provincial-level municipalities in mainland
China. As of December 31, 2012, this network comprised over 660 independent
distributors and over 690 independent sub-distributors who sell Synutra
products in approximately 27,000 retail outlets.
This press release contains "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995 that are based on our
current expectations, assumptions, estimates and projections about Synutra
International, Inc. and its industry. All statements other than statements of
historical fact in this release are forward-looking statements. In some cases,
these forward-looking statements can be identified by words or phrases such as
"anticipate," "believe," "continue," "estimate," "expect," "intend," "is/are
likely to," "may," "plan," "should," "will," "aim," "potential," "continue,"
or other similar expressions. The forward-looking statements included in this
press release relate to, among others, Synutra's goals and strategies; its
future business development, financial condition and results of operations;
the expected growth of the nutritional products and infant formula markets in
China; market acceptance of Synutra's products; the safety and quality of
Synutra's products; Synutra's expectations regarding demand for its products;
Synutra's ability to stay abreast of market trends and technological advances;
competition in the infant formula industry in China; PRC governmental policies
and regulations relating to the nutritional products and infant formula
industries, and general economic and business conditions in China. These
forward-looking statements involve various risks and uncertainties. Although
Synutra believes that the expectations expressed in these forward-looking
statements are reasonable, these expectations may turn out to be incorrect.
Synutra's actual results could be materially different from the expectations.
Important risks and factors that could cause actual results to be materially
different from expectations are generally set forth in Synutra's filings with
the Securities and Exchange Commission. The forward-looking statements are
made as of the date of this press release. Synutra International, Inc.
undertakes no obligation to update any forward-looking statements to reflect
events or circumstances after the date on which the statements are made or to
reflect the occurrence of unanticipated events.
SOURCE Synutra International, Inc.
Contact: Synutra International, Inc., Investor Relations Department,
Press spacebar to pause and continue. Press esc to stop.